Ashraf S. Ibrahim

Active 1992–2026

109
Papers
18,642
Citations
76
h-index
102
i10-index

Citations

Citations per year for Ashraf S. Ibrahim1993: 2 citations1995: 3 citations1996: 4 citations1997: 6 citations1998: 6 citations1999: 15 citations2000: 20 citations2001: 24 citations2002: 24 citations2003: 39 citations2004: 39 citations2005: 63 citations2006: 86 citations2007: 79 citations2008: 103 citations2009: 122 citations2010: 144 citations2011: 173 citations2012: 213 citations2013: 144 citations2014: 169 citations2015: 80 citations2016: 136 citations2017: 135 citations2018: 132 citations2019: 398 citations2020: 458 citations2021: 821 citations2022: 656 citations2023: 554 citations2024: 731 citations2025: 363 citations2026: 12 citations1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,297 citing papers, 24% of this breakdownUnited Kingdom: 345 citing papers, 6.4% of this breakdownGermany: 328 citing papers, 6.1% of this breakdownIndia: 328 citing papers, 6.1% of this breakdownChina: 304 citing papers, 5.6% of this breakdownFrance: 229 citing papers, 4.2% of this breakdownSpain: 179 citing papers, 3.3% of this breakdownCanada: 169 citing papers, 3.1% of this breakdownAustria: 151 citing papers, 2.8% of this breakdownItaly: 131 citing papers, 2.4% of this breakdownNetherlands: 131 citing papers, 2.4% of this breakdownAustralia: 125 citing papers, 2.3% of this breakdown
0%24%Other 31.3%

Fields

  • Medicine70.5%
  • Biochemistry, Genetics and Molecular Biology15.4%
  • Immunology and Microbiology5.1%
  • Agricultural and Biological Sciences3.3%
  • Environmental Science0.8%
  • Engineering0.8%
  • Other4.1%

Topics

  • Antifungal resistance and susceptibility22.6%
  • Fungal Infections and Studies14.7%
  • Pneumocystis jirovecii pneumonia detection and treatment2%
  • Plant Pathogens and Fungal Diseases1.9%
  • Nail Diseases and Treatments1.9%
  • Antibiotic Resistance in Bacteria1.8%
  • Other55.1%

Coauthors

All papers

Open in search
  1. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús Guinea, Claus Peter Heußel, Ashraf S. Ibrahim, Souha S. Kanj, Н Н Климко, Michaela Lackner, Frédéric Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong‐Gun Lee, Thomas Lehrnbecher, B. Lmimouni, Mihai Mareș, Georg Maschmeyer, Jacques F. Meis, Joseph Meletiadis, C. Orla Morrissey, Márcio Nucci, Rita Oladele, Livio Pagano, Alessandro C. Pasqualotto, Atul Patel, Zdeněk Ráčil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinkó, Anna Skiada, Monica A. Slavin, Rajeev Soman, Brad Spellberg, William J. Steinbach, Ban Hock Tan, Andrew J. Ullmann, Jörg Janne Vehreschild, Maria J. G. T. Vehreschild, Thomas J. Walsh, P. Lewis White, Nathan P. Wiederhold, Theoklis E. Zaoutis, Arunaloke Chakrabarti - The Lancet Infectious Diseases 2019 cited by 1,756

  2. COVID-19-associated fungal infections

    Authors: , , , , , , , - Nature Microbiology 2022 cited by 480

  3. Adaptive immunity induces mutualism between commensal eukaryotes

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 206

  4. Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections

    Authors: , - Journal of Fungi 2020 cited by 213

  5. Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells

    Authors: , , , , , , , , - PLoS Biology 2007 cited by 623

  6. A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2018 cited by 205

  7. A Candida auris –specific adhesin, Scf1 , governs surface association, colonization, and virulence

    Authors: , , , , , , , , , , , - Science 2023 cited by 129

  8. Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas F. Patterson, Nathan P. Wiederhold, David R. Andes, Taras V. Pogorelov, Charles D. Schwieters, Timothy M. Fan, Chad M. Rienstra, Martin D. Burke - Nature 2023 cited by 98

  9. Pathogenesis of Mucormycosis

    Authors: , , , - Clinical Infectious Diseases 2012 cited by 811

  10. A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 65

  11. Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections

    Authors: , , , , , , , , , - Journal of Fungi 2022 cited by 48

  12. Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

    Authors: , , - Clinical Microbiology Reviews 2005 cited by 1,522

  13. Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

    Authors: , , , , , , , , , - PLoS Pathogens 2009 cited by 462

  14. Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus

    Authors: , , , , , , , - Antimicrobial Agents and Chemotherapy 2020 cited by 84

  15. Challenges in the diagnosis and treatment of mucormycosis

    Authors: , , , , , - Medical Mycology 2017 cited by 563

  16. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection

    Authors: , , , , , , , , , - PLoS Pathogens 2019 cited by 148

  17. Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Microbiology 2021 cited by 102

  18. Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis

    Authors: , , , , , , , , - Antimicrobial Agents and Chemotherapy 2019 cited by 95

  19. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults

    Authors: , , , , , , , - Vaccine 2012 cited by 226

  20. Genomic Analysis of the Basal Lineage Fungus Rhizopus oryzae Reveals a Whole-Genome Duplication

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina A. Cuomo, Brian L. Wickes - PLoS Genetics 2009 cited by 391

  21. CotH3 mediates fungal invasion of host cells during mucormycosis

    Authors: , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 252

  22. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis

    Authors: , , , , , , , , , , - mBio 2020 cited by 113

  23. Aspergillus fumigatus CalA binds to integrin α5β1 and mediates host cell invasion

    Authors: , , , , , , , , - Nature Microbiology 2016 cited by 102

  24. Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection

    Authors: , , , , , , , , , - PLoS ONE 2012 cited by 194